Cargando…
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody
BACKGROUND: Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) are used for the treatment of various cancer types. However, immune-related adverse events (irAEs) occur in patients treated with ICIs. Several small-scale studies have reported the onset of irAEs and th...
Autores principales: | Matsuoka, Hiroshi, Hayashi, Takahiro, Takigami, Karen, Imaizumi, Kazuyoshi, Shiroki, Ryoichi, Ohmiya, Naoki, Sugiura, Kazumitsu, Kawada, Kenji, Sawaki, Akira, Maeda, Koutaro, Ando, Yousuke, Uyama, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362440/ https://www.ncbi.nlm.nih.gov/pubmed/32664888 http://dx.doi.org/10.1186/s12885-020-07142-3 |
Ejemplares similares
-
Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
por: Ando, Yosuke, et al.
Publicado: (2019) -
Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy
por: Ando, Yosuke, et al.
Publicado: (2015) -
Effect of renal function on pemetrexed-induced haematotoxicity
por: Ando, Yosuke, et al.
Publicado: (2016) -
Orchiectomy due to delayed severe scrotal hematocele after laparoscopic transabdominal preperitoneal repair for a giant inguinoscrotal hernia: a case report
por: Nakamura, Kenichi, et al.
Publicado: (2022) -
Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer
por: Ohta, Hideki, et al.
Publicado: (2017)